| Revenue | 12/31/2018 | 12/31/2017 | 7/31/2017 | 7/31/2016 |
| Total Revenue | 13,982.177 | 28,229.561 | 18,445.996 | 9,897.595 |
| Cost of Revenue | 23,694.916 | 9,346.862 | 3,171.599 | - |
| Gross Profit | -9,712.739 | 18,882.698 | 15,274.397 | 9,897.595 |
| Operating Expenses |
| Research Development | - | - | - | 2,808.757 |
| Selling General and Administrative | 11,477.701 | 15,181.824 | 8,022.132 | 14,827.317 |
| Non Recurring | - | - | - | - |
| Others | - | - | - | - |
| Total Operating Expenses | 35,172.617 | 24,528.686 | 11,193.731 | 17,636.074 |
| Operating Income or Loss | -21,190.44 | 3,700.874 | 7,252.265 | -7,738.479 |
| Income from Continuing Operations |
| Total Other Income/Expenses Net | 46.407 | 15.626 | -121.178 | -75.777 |
| Earnings Before Interest and Taxes | -21,190.44 | 3,700.874 | 7,252.265 | -7,738.479 |
| Interest Expense | - | - | -4 | -12 |
| Income Before Tax | -21,144.033 | 3,716.501 | 7,131.087 | -7,814.256 |
| Income Tax Expense | 51.283 | 405.991 | 550.474 | - |
| Minority Interest | - | - | - | - |
| Net Income From Continuing Ops | -21,195.316 | 3,310.51 | 6,580.613 | -7,814.256 |
| Non-recurring Events |
| Discontinued Operations | - | - | - | - |
| Extraordinary Items | - | - | - | - |
| Effect Of Accounting Changes | - | - | - | - |
| Other Items | - | - | - | - |
| Net Income |
| Net Income | -21,195.316 | 3,310.51 | 6,580.613 | -7,814.256 |
| Preferred Stock And Other Adjustments | - | - | - | - |
| Net Income Applicable To Common Shares | -21,195.316 | 3,310.51 | 6,580.613 | -7,814.256 |